## **Core Concept**
The question tests knowledge of fungal infections, specifically the portal of entry for *Aspergillus*, a type of mold that can cause aspergillosis. Understanding the common routes of entry for pathogens is crucial in microbiology and infectious diseases. *Aspergillus* species are ubiquitous in the environment, and their spores can be inhaled by humans.

## **Why the Correct Answer is Right**
The correct answer, inhalation, is the most probable portal of entry for *Aspergillus* because these fungi release spores into the air, which can then be inhaled by individuals. Once inhaled, the spores can germinate in the lungs, leading to various forms of aspergillosis, ranging from allergic reactions to invasive pulmonary aspergillosis, particularly in immunocompromised patients. The lungs' alveolar macrophages and other immune cells usually provide a first line of defense against inhaled pathogens, including fungal spores.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Ingestion is not a typical portal of entry for *Aspergillus*. While ingestion of fungal spores could potentially occur, it is not the primary or most probable route for *Aspergillus* infections.
- **Option B:** Direct inoculation into the skin could be a portal of entry for some pathogens, but it is not typical for *Aspergillus* infections, which are more commonly associated with respiratory infections.
- **Option C:** This option seems to be missing but assuming it refers to another route, any route other than inhalation would not be the primary portal of entry for *Aspergillus*.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that *Aspergillus* infections are particularly problematic in immunocompromised individuals, such as those with HIV/AIDS, undergoing chemotherapy, or on immunosuppressive therapy. The clinical presentation can vary widely, from allergic bronchopulmonary aspergillosis (ABPA) to chronic pulmonary aspergillosis and invasive aspergillosis.

## **Correct Answer:** . Inhalation